Marilyn Cherry-Burkett
Nurse Practitioner · Dothan, ALNPI 1730385451
Payments from drug & device makers
Across 216 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Novo Nordisk$931
- Dexcom, Inc.$486
- Lilly USA, LLC$364
- Abbott$325
- Bayer$172
- plus $1K from 28 others
What the payments were for
- Consulting fees$701%
- Travel & lodging$1,07319%
- Food & beverage$4,47579%
- Other$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $2,090 |
| Novo Nordisk | 38 | $931 |
| Dexcom, Inc. | 37 | $486 |
| Lilly USA, LLC | 15 | $364 |
| Abbott | 26 | $325 |
| Bayer | 11 | $172 |
| AbbVie | 7 | $148 |
| Biohaven Pharmaceuticals, Inc. | 5 | $144 |
| Corcept Therapeutics | 7 | $106 |
| AstraZeneca | 5 | $87 |
| Amarin Pharma, Inc. | 5 | $78 |
| Insulet Corporation | 2 | $71 |
| ANI Pharmaceuticals, Inc. | 3 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Ultragenyx Pharmaceutical Inc. | 3 | $61 |
| Radius Health, Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $38 |
| Ascendis Pharma Endocrinology Inc | 1 | $30 |
| Grifols USA, LLC | 2 | $28 |
| Baxter Healthcare | 1 | $26 |
| Welch Allyn | 1 | $26 |
| Smith+Nephew | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Sanofi | 1 | $20 |
| Seqirus USA Inc | 1 | $20 |
| Pfizer | 1 | $19 |
| Amgen | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Philips North America LLC | 1 | $14 |
| Recordati_rare_diseases_inc. | 1 | $12 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,457
- RYBELSUS$250
- Wegovy$232
- MOUNJARO$116
- NURTEC ODT$115
- INTELLIS ADAPTIVESTIM$112
How this compares
$5,670 in reported general payments places this provider in the 90th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 384 | $632,438 |
| Tresiba Flextouch U-200Insulin Degludec | 169 | $340,296 |
| MounjaroTirzepatide | 177 | $248,029 |
| TrulicityDulaglutide | 82 | $104,291 |
| Humalog Kwikpen U-200Insulin Lispro | 25 | $99,535 |
| Tresiba Flextouch U-100Insulin Degludec | 96 | $96,013 |
| JardianceEmpagliflozin | 107 | $94,455 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 42 | $73,961 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 41 | $62,660 |
| FarxigaDapagliflozin Propanediol | 49 | $46,657 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $46,539 |
| Humalog Kwikpen U-100Insulin Lispro | 72 | $39,096 |
| JanuviaSitagliptin Phosphate | 34 | $37,369 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 28 | $31,518 |
| InvokanaCanagliflozin | 24 | $25,313 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Fiasp, Novolog | $931 | $667,026423 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro, Humulin 70-30 | $364 | $378,283345 claims |
| Boehringer IngelheimJardiance, Tradjenta | $47 | $119,524135 claims |
| MerckJanuvia, Janumet Xr | $12 | $59,53159 claims |
| AstraZenecaFarxiga | $87 | $46,65749 claims |
| Johnson & JohnsonInvokana | $21 | $25,31324 claims |
| Sanofi-aventis U.S. LLCLantus | $63 | $6,31923 claims |
| AbbVieSynthroid | $148 | $2,73121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Dothan
- Hollie CrutchfieldDothan$22K
- Christina BellDothan$14K
- Shea CalhounDothan$14K
- Amanda PybusDothan$13K
- Tami CaldwellDothan$13K
- Alison HallDothan$12K
- Jennifer ParrishDothan$12K
- Amanda SewellDothan$11K
- Amy EthridgeDothan$11K
- Allison McAllisterDothan$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.